Current status, trends, and predictions in the burden of silicosis in 204 countries and territories from 1990 to 2019.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2023
Historique:
received: 04 05 2023
accepted: 28 06 2023
medline: 1 8 2023
pubmed: 31 7 2023
entrez: 31 7 2023
Statut: epublish

Résumé

Silicosis, a severe lung disease caused by inhaling silica dust, predominantly affects workers in industries such as mining and construction, leading to a significant global public health challenge. The purpose of this study is to analyze the current disease burden of silicosis and to predict the development trend of silicosis in the future the world by extracting data from the GBD database. We extracted and analyzed silicosis prevalence, incidence, mortality, and disability-adjusted life years (DALYs) data from the Global Burden of Disease 2019 program for 204 countries and territories from 1990 to 2019. The association between the Sociodemographic Index (SDI) and the burden of age-standardized rates (ASRs) of DALYs has been examined at the regional level. Jointpoint regression analysis has been also performed to evaluate global burden trends of silicosis from 1990 to 2019. Furthermore, Nordpred age-period-cohort analysis has also been projected to predict future the burden of silicosis from 2019 to 2044. In 2019, global ASRs for silicosis prevalence, incidence, mortality, and DALYs were 5.383, 1.650, 0.161, and 7.872%, respectively which are lower than that in 1990. The populations of 45-59 age group were more susceptible to silicosis, while those aged 80 or above suffered from higher mortality and DALY risks. In 2019, the most impacted nations by the burden of silicosis included China, the Democratic People's Republic of Korea, and Chile. From 1990 to 2019, most regions observed a declining burden of silicosis. An "M" shaped association between SDI and ASRs of DALYs for silicosis was observed from 1990 to 2019. The age-period-cohort analysis forecasted a decreasing trend of the burden of silicosis from 2019 to 2044. Despite the overall decline in the global silicosis burden from 1990 to 2019, some regions witnessed a notable burden of this disease, emphasizing the importance of targeted interventions. Our results may provide a reference for the subsequent development of appropriate management strategies.

Sections du résumé

Background
Silicosis, a severe lung disease caused by inhaling silica dust, predominantly affects workers in industries such as mining and construction, leading to a significant global public health challenge. The purpose of this study is to analyze the current disease burden of silicosis and to predict the development trend of silicosis in the future the world by extracting data from the GBD database.
Methods
We extracted and analyzed silicosis prevalence, incidence, mortality, and disability-adjusted life years (DALYs) data from the Global Burden of Disease 2019 program for 204 countries and territories from 1990 to 2019. The association between the Sociodemographic Index (SDI) and the burden of age-standardized rates (ASRs) of DALYs has been examined at the regional level. Jointpoint regression analysis has been also performed to evaluate global burden trends of silicosis from 1990 to 2019. Furthermore, Nordpred age-period-cohort analysis has also been projected to predict future the burden of silicosis from 2019 to 2044.
Results
In 2019, global ASRs for silicosis prevalence, incidence, mortality, and DALYs were 5.383, 1.650, 0.161, and 7.872%, respectively which are lower than that in 1990. The populations of 45-59 age group were more susceptible to silicosis, while those aged 80 or above suffered from higher mortality and DALY risks. In 2019, the most impacted nations by the burden of silicosis included China, the Democratic People's Republic of Korea, and Chile. From 1990 to 2019, most regions observed a declining burden of silicosis. An "M" shaped association between SDI and ASRs of DALYs for silicosis was observed from 1990 to 2019. The age-period-cohort analysis forecasted a decreasing trend of the burden of silicosis from 2019 to 2044.
Conclusion
Despite the overall decline in the global silicosis burden from 1990 to 2019, some regions witnessed a notable burden of this disease, emphasizing the importance of targeted interventions. Our results may provide a reference for the subsequent development of appropriate management strategies.

Identifiants

pubmed: 37521973
doi: 10.3389/fpubh.2023.1216924
pmc: PMC10372342
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1216924

Informations de copyright

Copyright © 2023 Yi, He, Zhang, Luo, Deng, Tang, Zhang, Zhou and Luo.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Int J Occup Environ Health. 2003 Oct-Dec;9(4):320-5
pubmed: 14664484
Lancet. 2023 Dec 17;400(10369):2221-2248
pubmed: 36423648
Am J Ind Med. 2019 Mar;62(3):183-191
pubmed: 30658007
Int J Infect Dis. 2021 Dec;113 Suppl 1:S7-S12
pubmed: 33716195
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
Am J Epidemiol. 2013 Nov 1;178(9):1424-33
pubmed: 24043436
Occup Environ Med. 2018 Jan;75(1):3-5
pubmed: 28882991
Bull World Health Organ. 2016 Oct 1;94(10):777-778
pubmed: 27843169
Occup Med (Lond). 2022 Aug 16;72(6):366-371
pubmed: 34729596
Occup Environ Med. 2020 Jun;77(6):407-414
pubmed: 32188634
Curr Opin Pulm Med. 2013 Mar;19(2):163-8
pubmed: 23254775
Ind Health. 2019 Aug 3;57(4):495-502
pubmed: 30344228
Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6414-9
pubmed: 9177232
Stat Med. 2003 Sep 15;22(17):2751-66
pubmed: 12939784
Stat Med. 2000 Feb 15;19(3):335-51
pubmed: 10649300
Inhal Toxicol. 2020 Aug;32(9-10):375-387
pubmed: 33006295
Chest. 2015 Sep;148(3):647-654
pubmed: 25654743
Gut. 2020 May;69(5):823-829
pubmed: 32001553
Occup Environ Med. 2019 Jan;76(1):17-21
pubmed: 30415232
Respirology. 2019 Dec;24(12):1220-1221
pubmed: 31407419
BMC Pulm Med. 2022 Jun 21;22(1):240
pubmed: 35729551
Int J Environ Res Public Health. 2021 Oct 20;18(21):
pubmed: 34769551
Int J Tuberc Lung Dis. 2007 May;11(5):474-84
pubmed: 17439668
J Occup Health. 2014;56(4):301-8
pubmed: 24953093

Auteurs

Xinglin Yi (X)

Department of Respiratory Medicine, Southwest Hospital of Third Military Medical University, Chongqing, China.

Yi He (Y)

Department of Cardiovascular Medicine Department, Southwest Hospital of Third Military Medical University, Chongqing, China.

Yu Zhang (Y)

Department of Cardiovascular Medicine Department, Southwest Hospital of Third Military Medical University, Chongqing, China.

Qiuyue Luo (Q)

Department of Cardiovascular Medicine Department, Southwest Hospital of Third Military Medical University, Chongqing, China.

Caixia Deng (C)

Department of Respiratory Medicine, Southwest Hospital of Third Military Medical University, Chongqing, China.

Guihua Tang (G)

Department of Respiratory Medicine, Southwest Hospital of Third Military Medical University, Chongqing, China.

Jiongye Zhang (J)

Department of Respiratory Medicine, Southwest Hospital of Third Military Medical University, Chongqing, China.

Xiangdong Zhou (X)

Department of Respiratory Medicine, Southwest Hospital of Third Military Medical University, Chongqing, China.

Hu Luo (H)

Department of Respiratory Medicine, Southwest Hospital of Third Military Medical University, Chongqing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH